About 400 reports

  • Global Overview of HIV, Men and Women, All Ages, 1990-2015
  • 4.5 QUALITY OF LIFE

PharmaPoint: Human Immunodeficiency Virus (HIV) - Global Drug Forecast and Market Analysis to 2025 Summary Global HIV therapeutics market was worth approximately US$16.3 billion in 2015, and GlobalData projects this market to reach a total of US$22.5 billion in sales by 2025, at a Compound Annual Growth Rate (CAGR)...

  • HIV AIDS
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.
  • GLOBAL HIV/AIDS THERAPEUTICS MARKET
  • GLOBAL ANTIVIRAL DRUGS MARKET SEGMENTATION BY THERAPIES

About Antiviral Drugs Antiviral drugs are agents used to cure a viral infection by inhibiting the growth of viral pathogens. There are two types of antiviral agents which includes narrow-spectrum antiviral agents and broad-spectrum antiviral agents. Technavio’s analysts forecast the global antiviral drugs market to grow...

  • HIV AIDS
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.
  • Global western blotting market by diagnostic laboratories 2015-2020 ($ millions)
  • Global western blotting market by diagnostic laboratories

About the Western Blotting Market Western blotting, also known as protein blotting or immunoblotting, is a technique under molecular biology that is used to detect and analyze proteins. The technique identifies specific proteins from a complex mixture of proteins present in a sample of tissues cells. Western blotting has high accuracy...

  • HIV AIDS
  • World
  • GE Healthcare Limited
  • Millipore Corporation
  • Thermo Fisher Scientific, Inc.

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • France
  • Japan
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##, HIV Ag, NAT, Western Blot C.

  • HIV AIDS
  • France
  • Japan
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • France
  • Japan
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United States
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Japan
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • France
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • United Kingdom
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Germany
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot C.

  • HIV AIDS
  • France
  • Germany
  • Italy
  • Demand

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand
  • Identifying Factors that Impede Market Growth
  • HIV rapid test kits market in EMEA

About Human Immunodeficiency Virus (HIV) Rapid Test Kits HIV rapid test kits help in determining the presence of antibodies for HIV in body fluids. The test kits include simple, single-use, disposable devices that can provide results within limited time. These devices are designed for using unprocessed specimens such as saliva...

  • HIV AIDS
  • World
  • Market Size
  • Alere Inc.
  • F. Hoffmann-La Roche Ltd.

Diagnostic Tests: HIV-##/ ##/ Combo, HIVAg/ HIV NAT, Western Blot, HTLV-I/ II C.

  • HIV AIDS
  • Pathology
  • Spain
  • Demand
  • Global HIV Infection New Cases: Statistics 2016
  • Global HIV-infected People: Statistics 2016

The global condom market is expected to cross $11 billion by 2023. Church & Dwight and Ansell & Reckitt Benckiser are the leading players in the market. Factors such as an increase in per capita discretionary income of people globally and a rapid growing number of dual-income households in developing as well as developed markets are major...

  • HIV AIDS
  • World
  • Market Size
  • Church & Dwight Co., Inc.
  • Reckitt Benckiser Group plc